Current availability status Semaglutide: FDA approved as Wegovy (weight loss) and Ozempic (diabetes) Prescription required Widely available through pharmacies Also available as research chemical Well-established sourcing Cagrilintide: NOT FDA approved (as of 2024) In Phase 3 clinical trials Not commercially available via prescription Only available as research chemical Limited vendors carry it CagriSema (combined product): Novo Nordisk's brand name In Phase 3 trials Not yet approved Anticipated FDA review 2025-2026 Will require prescription when approved Research chemical sourcing For semaglutide: Many established research chemical vendors Quality varies significantly Third-party testing essential Typical cost: $150-300 per 5mg vial Lasts 2-4 weeks at 2.4mg dose For cagrilintide: Very limited vendors currently Newer peptide, less available Quality even more variable Higher cost due to scarcity: $200-400 per 2.4mg vial Many vendors don't carry it yet Quality verification: Certificate of Analysis (COA) required Purity should be 95% Recent testing (within 6 months) Batch number matching Established vendor reputation Red flags: No testing documentation Suspiciously cheap prices New, unknown vendors Poor communication Inconsistent product quality reports See our best peptide vendors , are peptides legal , and research vs pharmaceutical peptides
Cureus 15 , e40311 (2023)
Proteomic analysis identified a total of 7182 proteins belonging to 90,605 peptides, among which 517 proteins were upregulated and 695 proteins were downregulated (Supplementary Fig
The aim of this study was to investigate the expression, roles, and mechanisms of action of the lncRNA DDX11-AS1 in HCC
Prog Cardiovasc Dis 63(3):383 Polonikov A (2020) Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients
